Sagility India [SAGILITY] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Sagility India Ltd.

NSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Sagility India Ltd. wins in 6 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Sagility India Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 22.86 36.73 Sagility India Ltd.
Price-to-Book Ratio 2.20 5.15 Sagility India Ltd.
Debt-to-Equity Ratio 13.85 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio 0.02 3.59 Sagility India Ltd.
EV/EBITDA 17.03 23.61 Sagility India Ltd.
Profit Margin (TTM) 12.61% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 19.66% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 19.66% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 6.47% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 4.88% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $10.90B $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 0.10% 0.97% Sun Pharmaceutical Industries Ltd.
1-Year Return 3.82% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 2.87 7.05 Sagility India Ltd.
Enterprise Value $204.35B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 3.03 6.66 Sagility India Ltd.
Gross Profit Margin (TTM) 38.15% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $14 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $1.81 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) N/A 0.11 N/A

Sagility India Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

SAGILITY
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Sagility India Ltd.-3.53%-2.97%-3.53%-2.88%-19.64%-22.86%
Sun Pharmaceutical Industries Ltd.-0.08%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Sagility India Ltd.3.82%43.95%43.95%43.95%43.95%43.95%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Sagility India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSAGILITYSUNPHARMA
Market Information
Market Cap i₹193.67B₹3.88T
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i16,631,9943,903,142
90 Day Avg. Volume i25,062,9853,253,866
Last Close₹40.13₹1,788.50
52 Week Range₹35.83 - ₹57.89₹1,548.00 - ₹1,916.60
% from 52W High-30.68%-6.68%
All-Time High₹57.89 (Oct 30, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-30.68%-8.77%
Growth Metrics
Quarterly Revenue Growth0.36%0.14%
Quarterly Earnings Growth0.23%0.16%
Financial Health
Profit Margin (TTM) i0.13%0.19%
Operating Margin (TTM) i0.20%0.26%
Return on Equity (TTM) i0.06%0.15%
Debt to Equity (MRQ) i13.856.68
Cash & Liquidity
Book Value per Share (MRQ)₹18.79₹324.46
Cash per Share (MRQ)₹1.28₹115.87
Operating Cash Flow (TTM) i₹9.67B₹110.84B
Levered Free Cash Flow (TTM) i₹5.39B₹109.29B
Dividends
Last 12-Month Dividend Yield i0.10%0.97%
Last 12-Month Dividend i₹0.05₹16.50

Valuation & Enterprise Metrics Analysis: Sagility India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSAGILITY (Apr 26, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.8636.73
Forward P/E i17.1429.48
PEG Ratio i0.023.59
Price to Sales (TTM) i2.877.05
Price to Book (MRQ) i2.205.15
Market Capitalization
Market Capitalization i₹193.67B₹3.88T
Enterprise Value i₹204.35B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i3.036.66
Enterprise to EBITDA i17.0323.61
Risk & Other Metrics
Beta iN/A0.11
Book Value per Share (MRQ) i₹18.79₹324.46

Financial Statements Comparison: Sagility India Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSAGILITY (2025)SUNPHARMA (2025)
Revenue/Sales i55.70B520.41B
Cost of Goods Sold i31.70B121.98B
COGS % of Revenue i56.9%23.4%
Gross Profit i24.00B398.44B
Gross Margin i43.1%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i8.40B125.81B
Operating Margin i15.1%24.2%
EBITDA i13.53B167.25B
EBITDA Margin i24.3%32.1%
Pre-Tax Income i7.60B137.52B
Pre-Tax Income % of Revenue i13.6%26.4%
Income Tax i2.21B27.72B
Income Tax % of Revenue i4.0%5.3%
Net Income (Profit) i5.39B109.65B
Profit Margin i9.7%21.1%

Balance Sheet & Liquidity Metrics

MetricSAGILITY (2025)SUNPHARMA (2025)
Cash & Equivalents i3.44B102.69B
Total Current Assets i18.21B526.24B
Total Current Assets % of Revenue i32.7%101.1%
Total Current Liabilities i10.89B181.94B
Total Current Liabilities % of Revenue i19.6%35.0%
Long-Term Debt i10.23B3.58B
Long-Term Debt % of Revenue i18.4%0.7%
Total Shareholders Equity i83.36B724.86B
Retained Earnings i8.83B578.62B
Retained Earnings % of Revenue i15.9%111.2%
Property, Plant & Equipment i9.22B100.36B

Cash Flow Statement Comparison

MetricSAGILITY (2025)SUNPHARMA (2025)
Operating Cash Flow i9.67B110.84B
Operating Cash Flow % of Revenue i17.4%21.3%
Capital Expenditures i-1.22B-20.68B
Free Cash Flow i10.90B119.44B
FCF Margin i19.6%23.0%
Debt Repayment i-3.70B-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricSAGILITYSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i4.68B2.40B
Float Shares i2.30B1.07B
% Held by Insiders i50.95%55.62%
% Held by Institutions i18.22%28.69%
% Held by Public i30.83%15.69%

Dividend Analysis & Yield Comparison: Sagility India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSAGILITYSUNPHARMA
Last 12-Month Dividend i₹0.05₹16.50
Last 12-Month Dividend Yield i0.10%0.97%
3-Year Avg Annual Dividend i₹0.02₹17.33
3-Year Avg Dividend Yield i0.10%0.51%
3-Year Total Dividends i₹0.05₹52.00
Ex-Dividend DateNov 12, 2025Feb 05, 2026